Related Experiment Video
Updated: Jan 22, 2026

Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children
Published on: September 11, 2018
Lead Poisoning in Children
1University of Kansas School of Medicine-Wichita, Wichita, KS, USA.
Insights
Asymptomatic lead poisoning in children is a growing concern. Early screening and intervention are crucial to prevent irreversible neurocognitive and behavioral impairments associated with elevated blood lead levels.
Area of Science:
- Pediatric Environmental Health
- Public Health
- Toxicology
Background:
- Asymptomatic lead poisoning is increasingly prevalent in children, with blood lead levels below 5 µg/dL linked to irreversible neurodevelopmental deficits.
- Key risk factors include young age, low socioeconomic status, pre-1978 housing, and consumption of imported goods.
- The U.S. Preventive Services Task Force found insufficient evidence for universal screening in 2019.
Purpose of the Study:
- To review current recommendations and guidelines for screening and managing childhood lead exposure.
- To highlight the importance of targeted screening based on local risk factors.
- To emphasize primary prevention strategies for lead poisoning.
Main Methods:
- Review of guidelines from the Centers for Disease Control and Prevention (CDC).
- Analysis of risk factors and developmental impacts of lead exposure.
- Discussion of treatment and prevention strategies.
Main Results:
- The CDC recommends targeted screening for Medicaid-eligible children and universal screening in high-risk areas.
- Specific screening schedules are advised in the absence of local guidelines.
- Environmental investigation and case management are recommended for identified cases.
Conclusions:
- Primary prevention is essential to mitigate the adverse effects of lead on child development.
- Targeted screening and prompt intervention are critical for managing childhood lead exposure.
- Further research may be needed to establish evidence-based universal screening protocols.
Abstract:
Asymptomatic lead poisoning has become more common in children. Blood lead levels of less than 5 µg per dL are associated with impairments in neurocognitive and behavioral development that are irreversible. Risk factors for lead poisoning include age younger than five years, low socioeconomic status, living in housing built before 1978, and use of imported food, medicines, and pottery. The U.S. Preventive Services Task Force released a recommendation in 2019 citing insufficient evidence to assess the balance of benefits and harms of universal screening for elevated blood lead levels in asymptomatic children and pregnant women. Local risk factors can be substantial, and the Centers for Disease Control and Prevention (CDC) recommends that states and cities formulate their own targeted screening guidelines. In the absence of local guidance, the CDC recommends screening all Medicaid-eligible children at 12 months and again at 24 months, or at least once between 36 and 72 months if not previously screened. The CDC also recommends universal screening in areas where more than 27% of the housing was built before 1950, or where at least 12% of children 12 to 36 months of age have blood lead levels greater than 10 µg per dL. Life-threatening lead levels are treated with chelation therapy, and lower levels should prompt case management and environmental investigations to identify and remove the source of exposure. Primary prevention strategies are essential to eliminate the harmful effects of lead on child development.
Related Concept Videos
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Prevention of Further Absorption of Poison
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Phase-lead and Phase-lag Controllers
Drug Dosing: Infants and Children
Time and frequency -Domain Interpretation of Phase-lead Control
The design of phase-lead control involves the strategic placement of poles and zeros to balance steady-state error and system...

